BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 4216878)

  • 1. [Whole body counting of 131I administered patients with hyperthyroidism, and estimations of absorbed doses of 131I to various organs (author's transl)].
    Saegusa K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Jun; 34(6):404-15. PubMed ID: 4216878
    [No Abstract]   [Full Text] [Related]  

  • 2. [Follow-up of 131I-therapy of hyperthyroidism (author's transl)].
    Kinoshita F; Maekawa A; Kohda E; Kokamoto J; Shichiri Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1976; 36(2):128-42. PubMed ID: 1064000
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of 131I-therapy for hyperthyroidism (author's transl)].
    Tsuchigame T; Yoshii H; Hirota Y; Yasunaga T; Fujimura K; Kaneko T; Katayama K; Ichihara Y; Fukui K; Nakamura I
    Rinsho Hoshasen; 1979 Mar; 24(3):355-60. PubMed ID: 547075
    [No Abstract]   [Full Text] [Related]  

  • 4. [131I-therapy of hyperthyroidism--10 years' follow-up study].
    Tsuchigame T; Yasunaga T; Hirota Y; Yano K; Ueno S; Bussaka H; Takahashi M; Yoshii H; Fukui K; Nakamura I; Kaneko T
    Rinsho Hoshasen; 1983 May; 28(5):589-93. PubMed ID: 6887615
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperthyroidism treated with I131. Late results (author's transl)].
    Atria P; Fuenzalida H; López JM; Michaud P; Arteaga E
    Rev Med Chil; 1981 Jul; 109(7):621-7. PubMed ID: 7330541
    [No Abstract]   [Full Text] [Related]  

  • 6. [Longsterm results of 131I treatment of hyperthyroidism--factors influencing the incidence of hypothyroidism (author's transl)].
    Hamada N; Ito K; Mimura T; Momotani N; Nishikawa Y; Ino E; Ban Y; Tsuchiya T
    Kaku Igaku; 1979 Dec; 16(8):1343-53. PubMed ID: 544871
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of atypical leukemia with monocytosis three years after 131I therapy of hyperthyroidism (author's transl)].
    Yonemitsu H; Kanazawa S; Kondo H; Yamaguchi K; Okuda K; Mikami K; Takasago M
    Rinsho Ketsueki; 1981 May; 22(5):673-7. PubMed ID: 6944518
    [No Abstract]   [Full Text] [Related]  

  • 8. An evaluation of the risk of developing hyperparathyroidism after 131I treatment for thyrotoxicosis.
    Fjälling M; Dackenberg A; Hedman I; Tisell LE
    Acta Chir Scand; 1983; 149(7):681-6. PubMed ID: 6650083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 131I therapy of hyperthyroidism: a five-year follow up.
    Khanna CM; Nath JK; Anand Y; Kochar BR
    J Indian Med Assoc; 1982 Dec; 79(11-12):153-6. PubMed ID: 7184967
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of myelogenous leukemia occurring 8 years following 131I therapy for hyperthyroidism (author's transl)].
    Sugiyama H; Shimada H; Senzaki S; Takahashi T; Horiuchi T; Hoshino T
    Rinsho Ketsueki; 1982 Mar; 23(3):356-64. PubMed ID: 6955535
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of hyperthyroidism using 131I: a retrospective study].
    Kamphuis JJ
    Ned Tijdschr Geneeskd; 1980 Jun; 124(26):1045-9. PubMed ID: 7402371
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of thyrotoxicosis with radioactive iodine (131I). Evaluation of a method].
    Rønnov-Jessen AD; Grønbaek P
    Ugeskr Laeger; 1986 Jun; 148(25):1528-31. PubMed ID: 3529542
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pursued objectives with the use of 131I for the treatment of hypothyroidism: analysis of 2 series receiving different doses].
    Aguayo J; Atria A; Pineda G
    Rev Med Chil; 1987 Apr; 115(4):308-13. PubMed ID: 3448739
    [No Abstract]   [Full Text] [Related]  

  • 14. Iodine-131 therapy of hyperthyroidism in pediatric patients.
    Clark JD; Gelfand MJ; Elgazzar AH
    J Nucl Med; 1995 Mar; 36(3):442-5. PubMed ID: 7884506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of 131iodine therapy of benign thyroid diseases (author's transl)].
    Pronath A; Buttermann G; Dirr W; Pabst HW
    MMW Munch Med Wochenschr; 1981 Dec; 123(51-52):1970-4. PubMed ID: 6798434
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravenous or oral 131I treatment of hyperthyroidism and thyroid cancer?].
    Müller KD; Grebe SF; Bock FL; Müller H; Fängewisch GL
    Nuklearmedizin; 1994 Jun; 33(3):87-92. PubMed ID: 8090631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of hyperthyroidism using iodine 131 (author's transl)].
    Baulieu JL; Leger FA; Savoie JC
    Chirurgie; 1978 Jun; 104(4):702-6. PubMed ID: 710230
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the potential absorbed doses from patients based on whole-body 131I clearance in thyroid cancer therapy.
    Willegaignon J; Stabin MG; Guimarães MI; Malvestiti LF; Sapienza MT; Maroni M; Sordi GM
    Health Phys; 2006 Aug; 91(2):123-7. PubMed ID: 16832193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer following iodine-131 therapy for hyperthyroidism.
    Hoffman DA; McConahey WM
    J Natl Cancer Inst; 1983 Jan; 70(1):63-7. PubMed ID: 6571923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histological changes caused by treatment with radioactive isotopes (author's transl)].
    Hirose F
    Rinsho Byori; 1974 Aug; 22(Suppl):202-14. PubMed ID: 4473607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.